ONWARD Medical Enhances Accessibility of ARC-EX System for Veterans

ONWARD Medical's ARC-EX System Now Accessible to Veterans

ONWARD Medical, renowned for its innovative spinal cord stimulation therapies, is excited to announce that its ARC-EX System, designed specifically for spinal cord injury patients, is now available on key US government purchasing platforms. This includes the Federal Supply Schedule and the General Services Administration (GSA) Advantage platforms.

Partnership with Lovell Government Services

The partnership with Lovell Government Services has been instrumental in facilitating this achievement. Lovell, recognized as a Service-Disabled Veteran-Owned Small Business (SDVOSB), is helping ONWARD Medical navigate the complexities of government contracting to ensure Veterans receive the advanced care they deserve.

A Commitment to Veterans

CEO Dave Marver expressed pride in making the ARC-EX System more accessible. He emphasized that the VA plays a pivotal role in serving Veterans with spinal cord injuries. The availability on these procurement platforms shortly after receiving federal authorization underscores ONWARD's dedication to equipping healthcare providers with the latest technologies for patient care.

The ARC-EX System's Significant Benefits

The introduction of the ARC-EX System aims to provide enhanced treatment options for those affected by spinal cord injuries. This innovative therapy is designed to offer targeted stimulation that helps improve upper extremity strength and functionality, significantly benefiting Veterans and their recovery journey.

Easing Procurement for Government Facilities

The ARC-EX System can now be obtained through the VA's Federal Supply Schedule National Acquisition Center (VA FSS NAC) and the GSA Advantage catalog—streamlining the purchasing process for medical equipment across VA centers, Military Health System (MHS) facilities, and other authorized government agencies. This immediate access ensures that health providers can swiftly integrate the ARC-EX System into their treatment protocols.

Conclusion: Enhancing Care for Spinal Injury Patients

The collaboration between ONWARD Medical and Lovell Government Services is transformative. Lovell, as ONWARD's logistics partner, will also work toward making the ARC-EX System available through the Defense Logistics Agency's Electronic Catalog (ECAT) soon, further enhancing access for government healthcare providers.

Future of Treatment with the ARC-EX System

The ARC-EX System represents a groundbreaking advancement in treatment methodologies for spinal cord injury. Cleared for sale in the US by the FDA, this therapy combines cutting-edge technology with practical applications for improving movement and independence in individuals living with these challenges. It symbolizes the future of spinal therapy and highlights ONWARD's commitment to innovate treatments that restore function.

Frequently Asked Questions

What is the ARC-EX System?

The ARC-EX System is a spinal cord stimulation therapy designed to restore movement and functionality in individuals with spinal cord injuries.

How can Veterans access the ARC-EX System?

Veterans can access the ARC-EX System through the Federal Supply Schedule and GSA Advantage platforms, making procurement efficient and streamlined.

Who collaborated with ONWARD Medical for the distribution?

ONWARD Medical partnered with Lovell Government Services, a Service-Disabled Veteran-Owned Small Business, to facilitate the distribution of the ARC-EX System.

What makes the ARC-EX System innovative?

The system utilizes targeted spinal cord stimulation to improve upper extremity strength and is considered a significant advancement in therapy for spinal cord injuries.

Is the ARC-EX System available for commercial use?

Yes, the ARC-EX System has received FDA clearance for commercial sale in the US and is now available through various government procurement platforms.

About The Author

Olivia Taylor here, a 26-year-old writer and financial advisor. After earning a degree in finance, I worked in the sector for years. I've always loved numbers and had a talent for simplifying difficult financial ideas so that anyone could understand. I wrote my first book because of this passion; it helps readers take charge of their financial futures by fusing real-life stories with useful financial advice.

Whether they are just beginning their careers, preparing for significant life events, or seeking to invest wisely, my goal with my writing is to enable people to make educated financial decisions. The foundation of my work is the conviction that security and freedom of the individual are largely determined by financial literacy. To further financial education, I run workshops and frequently write for financial blogs in addition to my books.

I like to travel, experience other cultures, and find inspiration in daily life when I'm not writing or examining market trends. My passion is utilizing sound financial practices to help people reach their financial objectives and lead the best lives possible.

Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.